FRI0075 Rheumatoid Arthritis Patients Receiving Glucocorticoid Exhibits Significant Bone Quality Abnormalities, Leading to Severe Bone Fragility Regardless of Bisphosphonate Treatment
doi 10.1136/annrheumdis-2017-eular.3514
Full Text
Open PDFAbstract
Available in full text
Date
June 1, 2017
Authors
Publisher
BMJ Publishing Group Ltd and European League Against Rheumatism